The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin
Open accessAbstract
The C-terminal "cell-binding domain" (CBD) of thrombospondin-1 (TS1) is a binding site for many cell types. Cell-binding peptides based on the sequence RFYVVM from the CBD of TS1 affinity label a 52-kDa cell surface glycoprotein, which we show is integrin-associated protein (IAP or CD47). IAP associates with alpha v beta 3 and thereby modulates the activity of several integrins. Cells that express IAP bind strongly to TS1, the CBD, and its active cell-binding peptides while IAP negative cells do not. The 52-kDa protein is affinity labeled on IAP-positive but not IAP-negative cells, and monoclonal antibodies against IAP specifically immunoprecipitate the affinity-labeled 52-kDa protein from lysates of IAP-positive cells. Consistent with the association of IAP with alpha v beta 3 integrin, the labeled 52-kDa protein is immunoprecipitated by an anti-alpha v beta 3 antibody. Endothelial cells exhibit chemotaxis toward TS1 (at concentrations above 10 nM) and RFYVVM peptides. Chemotaxis to both agents is specifically inhibited by a function blocking anti-IAP monoclonal antibody. These data establish IAP (CD47) as a receptor for the CBD of TS1 and suggest a mechanism for the well established effects of the CBD on cell motility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Tolsma, S., Volpert, O., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.2.497 · Cited by 573
Self-citationFelding-Habermann, B., & Cheresh, D. A. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90036-p · Cited by 413
Brown, E., Hooper, L., Ho, T., & Gresham, H. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.6.2785 · Cited by 407
Self-citationLindberg, F. P., Gresham, H. D., Schwarz, E., & Brown, E. J. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.2.485 · Cited by 379
Self-citationBlystone, S. D., Graham, I. L., Lindberg, F. P., & Brown, E. J. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.4.1129 · Cited by 254
Self-citationSchwartz, M. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.4.1003 · Cited by 238
The properdin-like type I repeats of human thrombospondin contain a cell attachment site.
Prater, C. A., Plotkin, J., Jaye, D., & Frazier, W. A. (1991) · The Journal of cell biology · doi:10.1083/jcb.112.5.1031 · Cited by 235
Self-citationTransendothelial migration of neutrophils involves integrin-associated protein (CD47).
Cooper, D., Lindberg, F. P., Gamble, J. R., Brown, E. J., & Vadas, M. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3978 · Cited by 219
Self-citation
Cited by
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581
The Rh blood group system: a review
Avent, N. D., & Reid, M. E. (2000) · Blood · doi:10.1182/blood.v95.2.375 · Cited by 704
CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells
Dawson, D. W., Pearce, S. F. A., Zhong, R., Silverstein, R. L., Frazier, W. A., & Bouck, N. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.707 · Cited by 676
Self-citationThe CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications
Chao, M. P., Weissman, I. L., & Majeti, R. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.01.010 · Cited by 649
Decreased Resistance to Bacterial Infection and Granulocyte Defects in IAP-Deficient Mice
Lindberg, F. P., Bullard, D. C., Caver, T. E., Gresham, H. D., Beaudet, A. L., & Brown, E. J. (1996) · Science · doi:10.1126/science.274.5288.795 · Cited by 607
Self-citationThrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth
Lawler, J. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00307.x · Cited by 540
Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2
Lawler, P. R., & Lawler, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006627 · Cited by 532
A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation
Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., & Landreth, G. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02665.2003 · Cited by 501
Lawler, J., Sunday, M., Thibert, V, Duquette, M., George, E. L., Rayburn, H., & Hynes, R. O. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1684 · Cited by 457
How macrophages deal with death
Lemke, G. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0167-y · Cited by 433
CD200 and membrane protein interactions in the control of myeloid cells
Barclay, A. N., Wright, G. J., Brooke, G., & Brown, M. H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02223-8 · Cited by 416
Thrombospondins: Multifunctional Regulators of Cell Interactions
Adams, J. C. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.25 · Cited by 406
The cell biology of thrombospondin-1
Chen, H., Herndon, M. E., & Lawler, J. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00107-4 · Cited by 393
Revisiting the matricellular concept
Murphy-Ullrich, J. E., & Sage, E. H. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.07.005 · Cited by 392
Integrin-associated Protein Is a Ligand for the P84 Neural Adhesion Molecule
Jiang, P., Lagenaur, C. F., & Narayanan, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.559 · Cited by 351
Role of red blood cells in thrombosis
Andrews, D. A., & Low, P. S. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199903000-00004 · Cited by 349
CD47 functions as a molecular switch for erythrocyte phagocytosis
Burger, P., Hilarius-Stokman, P., de Korte, D., van den Berg, T. K., & van Bruggen, R. (2012) · Blood · doi:10.1182/blood-2011-10-386805 · Cited by 338
Gavrilovskaya, I. N., Brown, E. J., Ginsberg, M. H., & Mackow, E. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3951-3959.1999 · Cited by 336
Self-citationVasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth
Pike, S. E., Yao, L., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H., Teruya-Feldstein, J., Wirth, P., Gupta, G., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2349 · Cited by 310
Isenberg, J. S., Martin-Manso, G., Maxhimer, J. B., & Roberts, D. D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2561 · Cited by 305
Seiffert, M., Cant, C., Chen, Z., Rappold, I., Brugger, W., Kanz, L., Brown, E. J., Ullrich, A., & Bühring, H.-J. (1999) · Blood · doi:10.1182/blood.v94.11.3633 · Cited by 303
Self-citationIsenberg, J. S., Ridnour, L. A., Dimitry, J., Frazier, W. A., Wink, D. A., & Roberts, D. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605040200 · Cited by 289
Self-citationThrombospondins 1 and 2 function as inhibitors of angiogenesis
Armstrong, L. C., & Bornstein, P. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00005-2 · Cited by 282
Sickle cell vaso-occlusion: multistep and multicellular paradigm
Frenette, P. S. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200203000-00003 · Cited by 274
Integrin signalling in neutrophils and macrophages
Berton, G., & Lowell, C. A. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(99)00003-0 · Cited by 224
Isenberg, J. S., Romeo, M. J., Yu, C., Yu, C. K., Nghiem, K., Monsale, J., Rick, M. E., Wink, D. A., Frazier, W. A., & Roberts, D. D. (2008) · Blood · doi:10.1182/blood-2007-06-098392 · Cited by 205
Self-citationIntegrin-mediated signal transduction
Longhurst, C. M., & Jennings, L. K. (1998) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050180 · Cited by 181
A Role for the αvβ3 Integrin in the Transmigration of Monocytes
Weerasinghe, D., McHugh, K. P., Ross, F. P., Brown, E. J., Gisler, R. H., & Imhof, B. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.2.595 · Cited by 130
Self-citationMiller, T. W., Kaur, S., Ivins-O'Keefe, K., & Roberts, D. D. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.02.009 · Cited by 109
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71
Wilson, K. E., Li, Z., Kara, M., Gardner, K. L., & Roberts, D. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3621 · Cited by 53
“(23), which has been shown to modulate a Vb3 integrin function (3) and T cell activation (24, 25).”
BackgroundMethodInfluential
Metadata
- Authors
- Gao, A.-G., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., & Frazier, W. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-01
- Volume
- 271
- Issue
- 1
- Pages
- 21-24
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1998225655
- Cited by
- 402
- References
- 28
- FWCI
- 12.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.